Term
|
Definition
made of phosphatidic acid (an intermediate from triacylglycerol biosynthesis)
most common phospholipid |
|
|
Term
biosynthesis of glycerophospholipids |
|
Definition
made in most cells of the body
Diacylglycerol+CDP-Choline=phosphatidylcholine
CDP-diacylglycerol+inositol=phosphatidylinositol
note: CDP must come from somewhere
phosphatidylserine->phosphatidylcholine (in liver) |
|
|
Term
remodel/degrade glycerophospholipids |
|
Definition
actions of PLA1 and PLA2 can add/remove to fatty acyl
PLA2/PLC also act in cell signaling
PLA2 releases arachidonic acid from membrane |
|
|
Term
|
Definition
most common in CNS
ceramide: basic unit of sphingolipids
Sphingosine+phosphatidylcholine->sphingomyelin |
|
|
Term
phosphatidylcholine in lung surfactant |
|
Definition
(PC) is part of lung surfactant
has 2 saturated residues (DPPC)
prevents lung colapse
less than 24 weeks, mostly sphingomyelin. 35 weeks become DPPC
adult resperatory distress syndrome: surfactant secreting alveolar type II pneumocites destroyed |
|
|
Term
|
Definition
mediate inflamation/hemostasis/muscle contraction/BP
produced in cells, used as needed (not stored)
made of arachidonic acid
|
|
|
Term
COX pathway
lipoxygenase pathway |
|
Definition
COX: Arachidonic acid->prosteglandin(PGs) + thromboxanes(TXs)
PGI1: inhibit platelet clumping,cause vasodilation
TXA2: stimulate platelet clumping,cause vasoconstriction
PGF2: stimulate uterine contraction during birt
Lipoxygenase: arachidonic acid->leukotrienes(LTs)
LTC/LTD/LTE: parts of SRS-A. cause bronchoconstriction/vasoconstriction/increas vascular permiability |
|
|
Term
|
Definition
decreas inflamation by inhibiting phospholipase A2 |
|
|
Term
|
Definition
NSAIDS: inhibits COX1 and COX2
selective COX2 inhib: celecoxib(celebrex) stops inflamation (viox and bextra taken out)
|
|
|
Term
|
Definition
sugar-containing derivitives of ceramide
found most in nerve tissue as cell membrane
used for communication
(eg) antigens (ABO), or receptors for bacterial toxins |
|
|
Term
lysosomal storage diseases
Niemann-Pick A/B
which enzyme damaged?
what lipid buildup?
symptoms? |
|
Definition
Nieman-Pick: lacks enzyme sphingomyelinase
can't convert sphingomyelin into ceramide
acumulates sphingomyelin
symptom: hepatosplenomegaly/retardation (type A) |
|
|
Term
Lysosomal Storage Disease
Fabry
what enzyme damaged?
what lipid buildup?
what symptoms? |
|
Definition
damage: α-galactosidase.
cant turn Gal-Gal-Glc-Cer into Gal-Glc-Cer
buildup of Gal-Gal-Glc-Cer (globosides)
Symptoms: skin rash/kidney & heart failure
treated with Fabrazyme |
|
|
Term
Lysosomal Storage Disease
Gaucher
what enzyme damaged?
what lipid buildup?
what symptoms? |
|
Definition
most common lysosomal storage disease
damage to β-glucosidase
cant convert glucocerebroside into ceramide
buildup of glucosylceramde (glucocerebrosides)
symptoms: hepatosplenomegalt, osteoperosis of long bones
treated with cerezyme |
|
|
Term
Lysosomal Storage Disease
Tay-Sachs
what enzyme damaged?
what lipid buildup?
what symptoms? |
|
Definition
lacks β-Hexosaminidase A
cant turn GM2 Ganglioside into GM3 Ganglioside
buildup of GM2 Ganglioside
Symptoms: retardation, muscular weakness, red macula, blindness |
|
|
Term
|
Definition
13 nobel prizes
complex 4 ring structure
synthesized from a 2 carbon substrate
essential function in membranes of animal cells
makes hormones and bile acids
forms plaques resulting in MI and strokes |
|
|
Term
|
Definition
3 Acetyl CoAs-> HMG CoA
reduction of HMGCoA to Mevalonate (rate limiting).
converting Mevalonate into cholesterol by isoprenoid intermediates
occurs in liver cytosol
Acetyl CoA from pyruvate or fatty acids |
|
|
Term
regulating biosynthesis of cholesterol |
|
Definition
phosphorylate HMGCoA reductase = inactivated
AMP levels (inactivates)
hormones insulin (activates)/glucagon (inactivates) |
|
|
Term
|
Definition
(at golgi)
S2p and S1p triggers SCAP to release SREBP to nucleus
HMG CoAR releases to raise cholesterol |
|
|
Term
|
Definition
at ER, cholesterol causes NSIG-SCAP-SREP complex to conformational change, so complex stays at ER
when no cholesterol, SCAP released from complex, and travels to Golgi |
|
|
Term
|
Definition
regulates HMGCoA reductase activity |
|
|
Term
|
Definition
inhibits FPP synthesis farnesilation
decreases osteoclast mediated breakdown of bone |
|
|
Term
|
Definition
cholesterol 7α-hydroxylase catalizes rate limiting
high cholesterol increases, bile reduces
after synthesis in liver, primary bile acid conjugated by gly or tyrene
Cholesterol+enzyme->CholylCoA
CholylCoA+Glycine=glychocolic acid (bile salt) |
|
|
Term
Cholelithiasis (gallstones) |
|
Definition
due to lack of bile salts in bile causes cholesterol precipitation |
|
|
Term
making steroids
where
rate limiting |
|
Definition
in adrenal cortex/testes/ovaries
rate limiting: cholesterol-> pregnenalone by mitochondrial desmolase.
pregnalone->progesterone |
|
|
Term
steroid hormone synthesis diseases
Cushing's syndrome
Addison's disease
congenital adrenal hyperplasia |
|
Definition
Cushing's: excess adrenal synthesis of cortisol
Addison's: adrenal insufficiency
CAH: overproduction of androgen |
|
|
Term
transport of cholesterol in blood |
|
Definition
transfered as lipoproteins (amphipathic)
Chylomicrons: triglycerides
LDL(bad) HDL(good) |
|
|
Term
Reverse Cholesterol transport |
|
Definition
HDL
"borrowed cholesterol transport"
transports excess cholesterol to liver for excretion
ABCA1:transport protein
LCAT: esterifies cholesterol to keep unidirectional movement of cholesterol
APP A1: activates LCAT |
|
|
Term
Familial Combined Hyperlipidemia
Familial Hypercholesterolemia
Polygenic Hypercholesterolemia |
|
Definition
(FCH)
leads to heart disease
overorduction of APOB-100 containing proteins
(FH)
less LDL receptors, so more LDL in blood
polygenic
non familial, leading cause of Hight cholesterol |
|
|
Term
pharmacological regulation of cholesterol
HMG CoA reductase inhib
Bile acid binding resins
Ezetamide
Nicotinic Acid
Fibrates |
|
Definition
HMG COA Reductase inhib: increase liver clearance of LDL, combo with ezetamide
Bile Acid binding resins: binds bile salts, prevent reabsorption, lowers lipid absorption, increase liver clearance of LDL
Ezetamide: acts on intestne&liver, inhibits NPC1L1 uptake of cholesterol, increase cholesterol loss in bile, combo with symvastatin
Nicotinic Acid: lowers liver synthesis of VLDL
Fibrates: inhibits liver synthesis of VLDL |
|
|
Term
3 carbon backbone of lipids synthesized from intermediates from |
|
Definition
|
|
Term
binding of glucogon in liver will ___ of HMGCoA and ___ of cholesterol biosynthesis |
|
Definition
|
|
Term
gall stones occur when there is a __% of lecithin and a ___ % of cholesterol |
|
Definition
|
|
Term
free fatty acids are transfered by |
|
Definition
|
|
Term
cholesterol is transfered by |
|
Definition
|
|
Term
to detox free radicals, erythrocytes use |
|
Definition
|
|
Term
what happens when someone who is G6PD deficient takes oxidative drugs? |
|
Definition
|
|
Term
what emulsifies dietary lipids? |
|
Definition
|
|
Term
long chain fatty acids produced during lipid digestion enter the circulation as |
|
Definition
|
|
Term
in fed state, free fatty acids generated in circulation by |
|
Definition
|
|
Term
during fasting, free fatty acid released from |
|
Definition
|
|
Term
most abundent in lung surfactant |
|
Definition
|
|
Term
linoleic acid is needed to make |
|
Definition
|
|
Term
what turns phosphotidylcholine into diacylglycerol and phsophocholine |
|
Definition
|
|
Term
how are triglycerides in blood? |
|
Definition
|
|
Term
lipoprotein lipase hydrolizes |
|
Definition
triglycerides in chylomicrons |
|
|
Term
fatty acid synthesis from acetyl coa occurs in liver cell's __ |
|
Definition
|
|
Term
dietary tryglycerides in lumen are hydrolized by |
|
Definition
|
|
Term
insuline cause clearance of chylomicrons by activating this enzyme___ |
|
Definition
|
|
Term
carnitine deficiency inhibits |
|
Definition
|
|
Term
damage to perivenous hepatocytes makes it hard for |
|
Definition
|
|
Term
fatty acid released from adipose tissue because action of |
|
Definition
|
|
Term
what enzyme is not needed for urea synthesis |
|
Definition
|
|
Term
impaied urea synthesis results inelevation of __ in blood |
|
Definition
|
|
Term
urea synthesis in liver because of enzyme |
|
Definition
|
|
Term
|
Definition
|
|
Term
nicotinamide is made of niacin and |
|
Definition
|
|
Term
what AA makes bile salts? |
|
Definition
|
|
Term
increased cholesterol ___ LDL receptors |
|
Definition
|
|
Term
damage to apolipoprotein CII will result in |
|
Definition
|
|
Term
what is not made from cholesterol |
|
Definition
|
|
Term
HDL transfers cholesterol from |
|
Definition
extrahepatic tissue to liver |
|
|
Term
lack of adrena enzyme to turn __ into __ makes a woman look manly |
|
Definition
progestins to glucocorticoids and mineralicorticoids |
|
|
Term
|
Definition
is made in blood by remodeling VLDL |
|
|
Term
|
Definition
|
|
Term
cholesterol in healthy adults |
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
Bile acid + glycene/taurene |
|
Definition
more effective fat absorption |
|
|
Term
|
Definition
many hydroxylation reactions |
|
|
Term
|
Definition
cant make glucocorticoids |
|
|
Term
chylomicron synthesis raised with |
|
Definition
|
|
Term
fatty acid biosynthesis inhibited by |
|
Definition
|
|
Term
lowers action of hormone sensative lipase |
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
Stomach: Hcl denatures protein, pepsinogen also breaks down proteins
SI: Bicarb neutralizes PH, Trypsin/chimotripsin/elastase breaks protein bonds. smaller pieces hydrolyzed by exopeptidase |
|
|
Term
|
Definition
transported through brush borders into intestinal epithelial
dipeptides hydrolized into AA
single AA released into circulation |
|
|
Term
|
Definition
1 remove amino group
2 amino becomes amonia and aspartate
3 use amonia and aspartate to make urea for scretion |
|
|
Term
transamination (catabolism) |
|
Definition
1 α-amino group transfered to α-ketogluterate to make α-ketoacid and glutamate
reversible
caried out by vitamin B6 dependent aminotransferases. aminotransferases specific to AA
glutamate can send amino group to oxaloacetate to make aspartate (enzyme AST)
or removed to make amonia (enzyme glut D) |
|
|
Term
|
Definition
release amonia for urea cycle
catalized by glutamate dehydrogenase
glutamate can use either NAD or NADPH
negative effectors: ATP/GTP
Posative effectors: ADP/GDP |
|
|
Term
|
Definition
amonia from glutamate
CO from bicarb
made in liver, sent to kidney
aspartate->urea and fumerate
low PH: secrete more NH4
high PH: secrete more NH3 |
|
|
Term
|
Definition
BUN (urea in blood) decreases
amonia in blood increase b/c liver not removing it for glutamate synthesis and urea synthesis |
|
|
Term
|
Definition
NH3 is substrate of urea synthesis, so urea synthesis goes up, also high P causes proteins/ezymes to work quicker
High PH: secrete more urea
low PH:secrete less urea, more NH4, so bicarb not used for urea, so can combo with acid to make C02 |
|
|
Term
what vitamins used for AA synthesis? |
|
Definition
|
|
Term
AA breakdown
4 carbon oxidized AA
4 carbon reduced AA
5 carbons in a row
3 carbons |
|
Definition
4 oxidized: oxaloacetate
4 reduced: succinyl
5: ketogluterate
3: pyruvate |
|
|
Term
|
Definition
reduced folate=folic acid
folate needed for mitosis, cofactor for enzymes to add a c from AA t purine/pyr
folate and B6 needed for methylation
methylation of DNA=activate DNA for mitosis |
|
|
Term
|
Definition
deficient of phenylalanine hydroxylase
cant turn phenylalanine->tyrosine
|
|
|
Term
|
Definition
lack of branched chain α-ketoacid dehydrogenase
cant release leucine/valine so plug AA in brain cell=adema/coma |
|
|
Term
|
Definition
irreverseable
acounts for 31%
1.) G6P->6-phosphogluconolactone by G6PD (rate limiting). NADPH competatively inhibits G6PD
2.) 6-phosphogluconolactone->6-phosphogluconate by 6-phosphogluconolactone hydrolase
3.) 6-phosphogluconate->R5P by 6-phosphogluconate dehydrogenase
net = G6P->1 R5P and 2 NADPH |
|
|
Term
|
Definition
reversible
acounts for 69%
turns R5P<->F6P and glyceraldehyde-3-P (glycolitic intermediates) |
|
|
Term
|
Definition
cell doing reductive biosynthesis,no division: NADPH
6 glucose->12 NADPH (when no R5P needed)
cell devides, no reduction biosynthesis: R5P
5 G6P->6 R5P (no NADPH made) ATP consumed in glycolysis
|
|
|
Term
|
Definition
used as an antioxident
also makes superoxides to help WBC kill bacteria
used to make NO to help WBC kill bacteria |
|
|
Term
|
Definition
Enzymatic: catalase and Glutathione peroxidase (more important), needs NADPH
non-enzymatic: Vitamin C/E, G-SH |
|
|
Term
|
Definition
class 1-4 higher class more extreme
sex linked, biggest effect on RBC
hemolitic anemia when oxidative stress.
low G6P causes hemolysis b/c WBC eats un-ID RBC |
|
|
Term
|
Definition
occurs in perivenous liver cells
doesnt use ATP
oxidative phosphorylation doesnt deal with NADPH |
|
|
Term
Digestion
Stomach:
Small Intestine:
|
|
Definition
Stomach: Mechanical breakdown, important for infants breakdown milk. adults breakdown 10-30% here.
Lingual Lipase & gastric Lipase hydrolize short to medium fatty acids.
Small Intestine: gut endocrine cells release:
Secretin: causes pancreas to release bicarb to neutralize PH
CCK: stimulates pancrease to releas digestive enzymes (pancretic lipase/cholesteryl ester hydrolase/phospholipase A2) and bile, and decreas motility, so less food goes into SI |
|
|
Term
|
Definition
Mediated by bile salts made from cholsterol
surfactant to break clumps into small pieces, with help from pancreatic lipase |
|
|
Term
|
Definition
--------------------------->2fatty acids+2monoacylglycerol
pancreatic lipase + colipase |
|
|
Term
|
Definition
------------------------> fatty acid + cholesterol
cholesteryl ester hydrolase |
|
|
Term
Phosphatidylcholine + H2O |
|
Definition
--------------------------------> Fatty acid + LysoPC
phospholipase A2
|
|
|
Term
|
Definition
fat products combine w/ bile salts to make micells
hydrophobic & bile salts are in mycells, phylic outside
mycells can pass through brush border lumen enterocyte |
|
|
Term
|
Definition
free fatty acids are activated by conjugation with CoA "fatty aceyl-CoA synthesis"
shipped out in lipoprotein particles (chylomicrons) into lymphatic system -> blood. |
|
|
Term
|
Definition
ALLI
fat not absorbed in intestine
inhibits pancreatic lipase
decreases absorption of triglycerides
|
|
|
Term
|
Definition
Questran
fat not absorbed in intestine
binds bile salts, preventd reabsorption
increases body clearance of LDL-cholesterol |
|
|
Term
|
Definition
Zetia
acts at intestine and liver through enterohepatic circulat
inhibits NPC1L1-mediated uptake of cholesterol by enterocytes
increase loss of cholesterol in bile
combined with simvastatin
|
|
|
Term
triacylglycerols (triglycerides)
Phospholipids |
|
Definition
Triglycerides: 90% of fats. fuel reserves. oxidation = acetyl CoA, FADH2, NADH.
Phospholipids: structural for membranes, and signaling
starvation, phospholipids metabolized into water soluble ketones |
|
|
Term
transporters for fat absorption |
|
Definition
|
|
Term
|
Definition
|
|
Term
Lipid Malabsorption
loss of lipids in feces (steatorrhea)
Cystic Fibrosis
Celiac Disease
Crohn's disease
Cholelithiasis
|
|
Definition
Cystic Fibrosis: most common fatal genetic disease in US.
acumulation of mucous causes pancreas insufficiency, lipid malabsorption.
treat: high protein/med/high fat diet. enteric pancreatic enzymes
Celiac: damaged intestine mucosa by glutten protein
Crohn's: inflamation of intestinal mucosa
Cholelithiasis: gallstones |
|
|
Term
Biosynthesis of fatty acids & triglycerides |
|
Definition
in liver, lactating mammary, some in kidney adipose
citrate shuttle exports acetyl CoA out of mitochondria
carboxylation of acetyl CoA to malonyl CoA= rate limiting
synthesis needs ATP& NADPH |
|
|
Term
transfer of acetyl CoA from mitochondria to cytosol |
|
Definition
acetyl changed to Citrate to exit mitochondria, (an intermediate form of of TCA cycle) in cytoplasm, cytrate cleaved by citrate lyase to regenerate acetyl CoA.
occurs when mitochondrial citrate is high (high ATP) |
|
|
Term
carboxylation of Acetyl CoA
|
|
Definition
rate limiting
Acetyl CoA + ATP-----ACC---> Malonyl CoA +ADP + P
biotin dependent
ACC allosteric regulation by citrate (+)& long chain acyl CoA (-)
phosphorylate/de by insulin (act),glucogon,EP (inact)
AMP-activated protein Kinase (inact)
|
|
|
Term
|
Definition
made from Acetyl CoA
Palmitic Acid can be elongated/desaturated.
catalized by enzymes in the ER
can add double bonds at C 4 5 6 9.
Essential Fatty Acid: linoleic acid because = at c 9,12,15 |
|
|
Term
storing fatty acids as triglycerides |
|
Definition
2 activated fatty acids are added to a glycerol phosphate
a phosphate group is removed, and a 3rd fatty acid is added to make triacylglycerol
triacylglycerols form lipid droplets for energy storage.
made in liver, incorperated into LDL for export |
|
|
Term
release of fatty acids from triacylglycerols |
|
Definition
activate enzyme HSL to remove first fatty acid from triacylglycerol
other lipases break off another fatty acid
Free Fatty Acids (FFA) enters blood, bind to albunun to go to organs/tissue |
|
|
Term
regulation of lipolysis and release of FFA
INSULIN
EP
Perilipin
Glyceroneogenesis |
|
Definition
Insulin: fasting=low insulin=disinhibits HSL activity
EP: promotes HSL through cAMP-mediated phosphorylat
Perilipin: protein on surface of lipid droplets, limits HSL access to tryglycerides. HSL can work if perilipin phosphorylated, so falls off of droplet.
Glyceroneogenesis: 30-40% released FFA reesterified to glycerol within adipocyte. |
|
|
Term
|
Definition
brings long chain fatty acyl CoAs
Malonyl CoA regulate the shuttle
Carnitine Acyltransferase 1: brings long chain fats into intermembrane mitochondria space
Carnitine Acyltransferase 2 brings them into matrix |
|
|
Term
|
Definition
oxidation-hydration-oxidation-thiolysis
removes acetyl parts of fatty acid
makes FADH2 and NADH
1 palmitoyl CoA makes net 129 ATP |
|
|
Term
alternate fatty acid oxidation
Peroxisomes:
ER (Microsomal) |
|
Definition
Peroxisomes: verry long chain fatty acids, α β oxidation (no net ATP). smaller pieces sent to mitochondria
ER: Omega oxidation, cytochrome P450, dicarboxylic acids |
|
|
Term
|
Definition
AMP activates AMPK (means high energy present)
high AMP activates AMPK by
Allosteric activation, phosphorylation, inhibit dephos
AMP also regulates digestive enzymes, regulates food intake. |
|
|
Term
MCAD deficiency
medium chain acyl CoA Dehydrogenase |
|
Definition
blood medium chain fats go up
glucose in blood goes down
ketone bodies go down
severe hypoglycemia |
|
|